Treatment Registry
TR-0228 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by Telezen MD · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$268

Medication · Monthly Plan$268

Added from the figures recorded below.

Price

TermPer monthCharged today
Monthly Plan

Monthly Plan $268 /mo Billed monthly

source

Per month$268Charged today$268
Quarterly Plan

Quarterly Plan $233 /mo $698 every 3 mo

source

Per month$233Charged today$698
Semi-Annual Plan

Semi-Annual Plan $199 /mo $1,198 every 6 mo

source

Per month$199Charged today$1,198
Annual Plan

Compounded Tirzepatide Plan BEST VALUE Annual Plan $157 /mo $1,888 every 12 mo

source

Per month$157Charged today$1,888
Visit Telezen MD

We earn nothing from this link. Telezen MD has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

StatesAll 50 states
PrescriberAsynchronous review
Cancellation“Cancellation requests must be submitted within 12 hours of placing your order by contacting support@telezenmd.com. ... If a licensed medical provider has reviewed your case prior to your cancellation request, a $35 doctor visit fee will be deducted from any eligible refund.”

Not yet checked: pharmacy, membership and consult fee.

Recorded from telezenmd.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026Also publishes a '180-Day Weight Loss Guarantee' -- a refund of medication fees if a patient shows no measurable weight loss after 180 consecutive days of full participation, minus the non-refundable $35 doctor visit fee.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0228
Readings
1

Related records

What else Telezen MD sells

All Telezen MD programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Telezen MD compounded tirzepatide (TR-0228). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0228

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.